Hep C Drug Boceprevir is Faster and Better
The FDA reported encouraging news regarding Merck's Hepatitis C drug, boceprevir.
Continue reading »General Hepatitis C News/Updates
Idera's Hep C Drug Put on Hold
A Hepatitis C Phase 2 trial for Idera's IMO-2125 has been halted due to preliminary data linking the drug to cancerous growth in lab rats.
Continue reading »Seven Tips to Boost HCV Therapy Adherence
A successful Hepatitis C treatment outcome hinges on medication adherence. Review these seven tips for improving treatment adherence to maximize your chance of beating this virus.
Continue reading »IL28B Diagnostic Test Now Widely Available
Available to physicians, other healthcare providers and drug companies for research purposes, Quest Diagnostics now offers a test to identify IL28B - the genetic variant that helps predict responsiveness to interferon-based therapy for Hepatitis C.
Continue reading »Should You Include Coconut Oil in Your Hep C Wellness Plan?
Apr 20, 2011
11 Comments
Possessing attributes that could benefit someone with chronic Hepatitis C, discover why coconut oil consumption is not necessarily an ideal dietary staple.
Continue reading »Are Early Menopause and Hepatitis C Treatment Response Connected?
Compared to women in their childbearing years, menopausal women have a disadvantage in the battle against Hepatitis C. However, those who begin menopause prematurely have an even greater hurdle to overcome.
Continue reading »Antidepressants Improve Hep C Therapy Adherence
An observational analysis has found that those on antidepressant medications during Hepatitis C treatment are more likely to complete interferon-based therapy.
Continue reading »Telaprevir's Chemistry Speeds HCV Treatment Time
Upon further study of telaprevir, researchers have determined that it may dramatically shorten the time required for successful Hepatitis C therapy.
Continue reading »Are the Epstein-Barr and Hepatitis C Viruses Linked?
Mar 28, 2011
1 Comment
What do the Epstein-Barr virus and Hepatitis C virus have in common? Not very much that will impact anyone with either condition; however, their connection could guide future research to eventually find a Hepatitis C cure.
Continue reading »Preventing Re-infection With Hep C Post-Transplant
Intended to prevent the Hepatitis C virus from entering liver cells, ITX-5061 is being tested in a Phase 1b trial that could reduce liver transplant re-infection rates.
Continue reading »
